We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Outlines Statistical Methods for Clinical Trials with Multiple Endpoints
The item has been added to your shopping cart.
FDA Outlines Statistical Methods for Clinical Trials with Multiple Endpoints
The FDA issued a draft guidance urging sponsors to work to control error rates before launching clinical trials with multiple endpoints, and provided several examples of appropriate statistical methods.